Skip to main content
. 2017 Aug 8;8(53):91795–91802. doi: 10.18632/oncotarget.20030

Figure 2.

Figure 2

A: Initial study. B: PET scan prior to initiation of Pembrolizumab. C: PET scan after 4 cycles of Pembrolizumab showing progression. D: Virtual Complete response after 6 cycles of PC post Pembrolizumab progression.